| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.07. | Pharmadrug Inc (2): Pharmadrug enters LOI to acquire 40% of Canurta | 3 | Stockwatch | ||
| 30.07. | Pharmadrug Inc (2): Pharmadrug corrects July 30 NR | 1 | Stockwatch | ||
| 30.07. | Pharmadrug Inc (2): Pharmadrug resumes at 9:30 a.m. PT | 1 | Stockwatch | ||
| 30.07. | PharmaDrug Inc.: PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc. | 596 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 30.07. | Pharmadrug Inc (2): Pharmadrug halted at 6:33 a.m. PT | 2 | Stockwatch | ||
| 17.06. | Pharmadrug Inc (2): Pharmadrug director, CEO Steen resigns | 3 | Stockwatch | ||
| 16.06. | PharmaDrug CEO Rob Steen steps down | 3 | Seeking Alpha | ||
| 16.06. | PharmaDrug Inc.: PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors | 400 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| PHARMADRUG Aktie jetzt für 0€ handeln | |||||
| 06.06. | Pharmadrug Inc (2): Pharmadrug puts itself on the block | 3 | Stockwatch | ||
| 06.06. | PharmaDrug Inc.: PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value | 317 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 15.11.24 | PharmaDrug Inc.: PharmaDrug Announces Issuance of Debenture Units | 888 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 31.10.24 | PharmaDrug Inc.: PharmaDrug Announces Proposed Issuance of Debenture Units | 542 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 31.10.24 | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases | 439 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,430 | -1,77 % | Aurora Cannabis Inc (3): Aurora Cannabis to issue Q2 fiscal 2026 results Nov. 5 | ||
| CANOPY GROWTH | 1,134 | -2,41 % | Stocks in Play: Canopy Growth Corporation | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 1,254 | -1,84 % | Tilray Brands-Aktie sorgt für Gesprächsstoff - was Anleger jetzt genau verfolgen müssen! | ||
| INNOCAN PHARMA | 10,400 | +4,00 % | InnoCan Pharma: Wie das "Wunder" funktioniert! | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| DERMAPHARM | 32,800 | -1,20 % | Kurs der Dermapharm-Aktie verharrt auf Vortags-Niveau (31,85 €) | Der Kurs der der Dermapharm-Aktie kommt kaum von der Stelle. Der jüngste Kurs betrug 31,85 Euro. Ein geringes Minus von 0,78 Prozent zeigt die Kurstafel für der Anteilsschein von Dermapharm an. Die... ► Artikel lesen | |
| CRONOS GROUP | 2,110 | -2,85 % | Cronos Group Inc: Cronos Group to hold Q3 2025 results call Nov. 6 | ||
| VIATRIS | 8,886 | -1,18 % | How Viatris is Fighting Infectious Disease | NORTHAMPTON, MA / ACCESS Newswire / October 21, 2025 / Viatris has a long history in the fight against infectious disease, which accounts for eight of the top 10 causes of death in low-income countries.1... ► Artikel lesen | |
| SYNBIOTIC | 2,605 | -2,07 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Stellungnahme
SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,490 | -1,32 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 6,345 | -2,68 % | Green Thumb Industries Inc: Green Thumb Industries to release Q3 results Nov. 5 | ||
| SNDL | 1,885 | -1,93 % | SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting Results | EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders... ► Artikel lesen | |
| CRESCO LABS | 1,061 | +0,66 % | Cresco Labs to Report Third Quarter 2025 Financial Results on November 5, 2025 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,070 | -17,90 % | XFRA 0NF0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMYDECINE INNOVAT.GRP... ► Artikel lesen |